Karyopharm Therapeutics Inc. Shareholders' Equity
Karyopharm Therapeutics Inc. (KPTI) had Shareholders' Equity of -$330.17 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-13
- 2026-06-30: Stockholders' Equity Attributable to Parent -$330.17M.
- 2026-03-31: Stockholders' Equity Attributable to Parent -$265.65M.
- 2025-12-31: Stockholders' Equity Attributable to Parent -$292.93M.
- 2025-09-30: Stockholders' Equity Attributable to Parent -$269.26M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | -$330.17M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | -$265.65M 10-Q · filed 2026-08-13 | |
| 2025-12-31 | -$292.93M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | -$269.26M 10-Q · filed 2025-11-03 | |
| 2025-06-30 | -$238.93M 10-Q · filed 2026-08-13 | |
| 2025-03-31 | -$205.88M 10-Q · filed 2026-08-13 | |
| 2024-12-31 | -$186.02M 10-Q · filed 2026-08-13 | |
| 2024-09-30 | -$159.65M 10-Q · filed 2025-11-03 | |
| 2024-06-30 | -$132.14M 10-Q · filed 2025-11-03 | |
| 2024-03-31 | -$168.96M 10-Q · filed 2025-08-11 | |
| 2023-12-31 | -$136.21M 10-K · filed 2026-02-13 | |
| 2023-09-30 | -$100.40M 10-Q · filed 2024-11-05 | |
| 2023-06-30 | -$71.25M 10-Q · filed 2024-11-05 | |
| 2023-03-31 | -$45.17M 10-Q · filed 2024-08-06 | |
| 2022-12-31 | -$16.66M 10-K · filed 2026-02-13 | |
| 2022-09-30 | -$140.28M 10-Q · filed 2023-11-02 | |
| 2022-06-30 | -$116.34M 10-Q · filed 2023-11-02 | |
| 2022-03-31 | -$83.08M 10-Q · filed 2023-08-02 | |
| 2021-12-31 | -$79.67M 10-K · filed 2025-02-19 | |
| 2021-09-30 | -$125.98M 10-Q · filed 2022-11-03 | |
| 2021-06-30 | -$83.13M 10-Q · filed 2022-11-03 | |
| 2021-03-31 | -$39.64M 10-Q · filed 2022-08-04 | |
| 2020-12-31 | $50.55M 10-K · filed 2024-02-29 | |
| 2020-09-30 | $83.77M 10-Q · filed 2021-11-03 | |
| 2020-06-30 | $129.80M 10-Q · filed 2021-11-03 | |
| 2020-03-31 | $166.15M 10-Q · filed 2021-08-05 | |
| 2019-12-31 | $49.77M 10-K · filed 2023-02-17 | |
| 2019-09-30 | $59.87M 10-Q · filed 2020-11-02 | |
| 2019-06-30 | $82.47M 10-Q · filed 2020-11-02 | |
| 2019-03-31 | $121.28M 10-Q · filed 2020-08-04 | |
| 2018-12-31 | $183.17M 10-K · filed 2022-03-01 | |
| 2018-09-30 | $171.08M 10-Q · filed 2019-11-04 | |
| 2018-06-30 | $213.47M 10-Q · filed 2019-11-04 | $213.47M 10-Q · filed 2018-08-07 |
| 2018-03-31 | $95.53M 10-Q · filed 2019-08-07 | $95.53M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $129.46M 10-K · filed 2021-02-24 | |
| 2017-09-30 | $141.18M 10-Q · filed 2017-11-02 | |
| 2017-06-30 | $166.71M 10-Q · filed 2017-08-08 | |
| 2017-03-31 | $138.36M 10-Q · filed 2017-05-04 | |
| 2016-12-31 | $162.24M 10-K · filed 2020-02-26 | |
| 2016-09-30 | $166.93M 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $153.57M 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $177.04M 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $198.37M 10-K · filed 2019-02-28 | |
| 2015-09-30 | $220.59M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $247.33M 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $275.52M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $206.79M 10-K · filed 2018-03-15 | |
| 2014-09-30 | $227.80M 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $131.68M 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $144.10M 10-Q · filed 2014-05-08 | |
| 2013-12-31 | $154.93M 10-K · filed 2017-03-16 | |
| 2013-09-30 | -$47.78M 10-Q/A · filed 2013-12-23 | |
| 2012-12-31 | -$27.88M 10-K · filed 2016-03-15 | |
| 2011-12-31 | -$12.65M 10-K · filed 2015-03-13 | |
| 2010-12-31 | -$2.38M 10-K · filed 2014-03-21 | |
| 2009-12-31 | -$179.00K 10-K · filed 2014-03-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |